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Immunoresponsive gene 1 (Irg1) is highly expressed in mammalian
macrophages during inﬂammation, but its biological function has
not yet been elucidated. Here, we identify Irg1 as the gene coding
for an enzyme producing itaconic acid (also known as methylene-
succinic acid) through the decarboxylation of cis-aconitate, a tricar-
boxylic acid cycle intermediate. Using a gain-and-loss-of-function
approach in both mouse and human immune cells, we found Irg1
expression levels correlating with the amounts of itaconic acid,
a metabolite previously proposed to have an antimicrobial effect.
We puriﬁed IRG1 protein and identiﬁed its cis-aconitate decarbox-
ylating activity in an enzymatic assay. Itaconic acid is an organic
compound that inhibits isocitrate lyase, the key enzyme of the
glyoxylate shunt, a pathway essential for bacterial growth under
speciﬁc conditions. Here we show that itaconic acid inhibits the
growth of bacteria expressing isocitrate lyase, such as Salmonella
enterica and Mycobacterium tuberculosis. Furthermore, Irg1 gene
silencing in macrophages resulted in signiﬁcantly decreased intra-
cellular itaconic acid levels as well as signiﬁcantly reduced antimi-
crobial activity during bacterial infections. Taken together, our
results demonstrate that IRG1 links cellular metabolism with im-
mune defense by catalyzing itaconic acid production.
During inﬂammatory responses, activated peripheral macro-phages and microglial cells, the resident immune cells in the
central nervous system, produce an array of inﬂammatory cyto-
kines and free radicals that are responsible for their antimicro-
bial activity (1). Depending on the pathogens and the cytokine
environment, macrophages are able to acquire a large spectrum
of different phenotypes having speciﬁc pro- or anti-inﬂammatory
properties (2, 3). Similar observations have been made in
microglial cells, where the pro- or anti-inﬂammatory states have
been elicited by different cytokines or bacterial components (4).
In this context, gene expression proﬁling studies of murine
macrophages and microglial cells have identiﬁed immunores-
ponsive gene 1 (Irg1) as one of the most highly up-regulated
genes under proinﬂammatory conditions, such as bacterial
infections (5–9). Increased Irg1 expression levels have also been
detected in chicken spleen macrophages after infection with
Salmonella enterica (10). Furthermore, it has been shown that
IRG1 could play an important role in the susceptibility toward
Marek disease virus (11). Irg1 was originally identiﬁed as a 2.3-kb
cDNA from a library synthesized from mRNA isolated from
a murine macrophage cell line after LPS stimulation (12). Irg1 is
also highly expressed in the early events leading to implantation
in the pregnant uterus (13, 14), the speciﬁc phase in which a high
level of inﬂammatory cytokines are secreted by the endometrial
cells as well as by cells of the immune system that are recruited to
the site of implantation (15). Interestingly, Irg1 has been used to
classify functional proﬁles of neurotoxic C-C chemokine receptor
9+Irg1+ and neurosupportive C-X-C chemokine receptor 3+Irg1−
microglia in vivo (16). Although no mitochondria targeting
signal sequence could be identiﬁed in the IRG1 amino acid
sequence, IRG1 protein has been reported to associate with
mitochondria (6).
Taken together, these data indicate an important role of Irg1
during immune response. Although expression levels of Irg1
have been extensively studied, its cellular function has not been
addressed and is unknown. Based on sequence homology, IRG1
has been classiﬁed into the MmgE/PrpD family (17), which
contains some proteins for which enzymatic activities have been
identiﬁed in microorganisms (18). To elucidate if mammalian IRG1
exhibits an enzymatic function, we performed siRNA-mediated
silencing of its expression in various cell models under inﬂam-
matory conditions and performed a nontargeted metabolomics
analysis to detect signiﬁcantly affected metabolites. Based on this
analysis, we were able to elucidate the function of IRG1 as an
enzyme catalyzing the production of the antimicrobial metabo-
lite itaconic acid by decarboxylating cis-aconitate.
Results and Discussion
IRG1 Function. To investigate whether IRG1 has a potential en-
zymatic function, we analyzed the metabolomics proﬁle of siRNA-
mediated Irg1 silencing under LPS stimulation in RAW264.7 cells.
We ﬁrst conﬁrmed that the silencing of Irg1 resulted in an 80%
decrease of Irg1 mRNA level compared with nonspeciﬁc siRNA
control (Fig. 1A). We detected very low levels of Irg1 mRNA (17-
fold less compared with LPS-activated cells) in nonactivated
macrophages. After silencing of Irg1 in RAW264.7 cells, we
measured 260 intracellular metabolites and, of these, we found
that 5 were signiﬁcantly different compared with untreated
RAW264.7 cells (Welch’s t test, P < 0.05). Most strikingly, we
observed that the metabolite most signiﬁcantly affected by Irg1
silencing was itaconic acid (P = 2.5 × 10−8). This metabolite was
very recently discovered by Strelko and colleagues in LPS-activated
macrophages (19). However, until now, the enzyme catalyzing its
production has not been described. Based on our experiments, the
silencing of Irg1 elicited a 60% decrease of itaconic acid compared
with control conditions (Fig. 1A). Only low levels of the metabolite
(11.5-fold less compared with LPS-activated cells) were measured
in resting macrophages. Having identiﬁed itaconic acid as the main
affected metabolite by Irg1 silencing, we performed an intracellular
quantiﬁcation of this compound and found a concentration of
3 mM in BV2 retroviral-immortalized microglia (BV-2) cells and
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8 mM in RAW264.7 mouse macrophages after LPS treatment
(LPS 10 ng/mL) (Fig. 1B). We measured similar amounts in
murine primary microglial cells induced by LPS treatment (Fig.
S1). Such high intracellular itaconic acid concentrations after
LPS treatment clearly point toward an immunological function
of this metabolite.
To further study the metabolic activity of IRG1, we overex-
pressed murine Irg1 in A549 human lung cancer cells. We found
that these cells contained high amounts of both Irg1 gene tran-
script and itaconic acid metabolite (0.2 ± 0.05 mM) 24 h after
transfection, but not in nontransfected cells or in cells trans-
fected with an empty control plasmid, in which Irg1 mRNA and
itaconic acid were below detection limit (Fig. 1 C and D).
Finally, to investigate the dynamics of Irg1 expression and
itaconic acid production after a proinﬂammatory stimulus, we
analyzed RAW264.7 cells activated with LPS (10 ng/mL) at
different time points. Although Irg1 transcript was already pro-
duced after 2 h, signiﬁcant amounts of itaconic acid could be
measured starting 6 h after LPS treatment (Fig. 1E). The time-
course of Irg1 expression is in line with observed expression
proﬁles of other proinﬂammatory cytokines. The positive time-
dependent correlation between Irg1 expression and itaconic acid
levels further support the cellular role of IRG1 in itaconic
acid production.
Itaconic Acid Metabolic Pathway. Intriguingly, murine IRG1 shows
a 23% amino acid sequence identity to the enzyme cis-aconitate
decarboxylase (CAD) expressed by the fungus Aspergillus terreus
(Fig. S2). In fact, IRG1 is evolutionary conserved across a large
set of species (Fig. S3). This fungus is commonly used for the
biotechnological production of itaconic acid at an industrial scale
(20). The biosynthesis of this dicarboxylic acid has been of in-
terest because it can be used as a starting material for chemical
synthesis of polymers (21). The fungal CAD enzyme catalyzes
the formation of itaconic acid by decarboxylating cis-aconitate to
itaconic acid (22). To determine if mammalian IRG1 has a sim-
ilar function as CAD in A. terreus, we performed stable-isotope
labeling experiments. We incubated LPS-activated RAW264.7
macrophages with uniformly 13C-labeled glucose (U-13C6). Cit-
rate synthase catalyzes the transfer of two labeled carbon atoms
from acetyl-CoA to oxaloacetate resulting in M2 cis-aconitate
A
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Fig. 1. (A) Levels of mRNA (left y axis, black bars) or itaconic acid (right y axis, gray bars) in resting (Ctr) or LPS-activated RAW264.7 macrophages transfected
with either siRNA speciﬁc for Irg1 or with siRNA Ctr. Metabolites and RNA extractions were performed after 6 h of stimulation. The levels of Irg1mRNA were
determined by real-time RT-PCR and normalized using L27 as a housekeeping gene. Each bar represents the average expression fold change (± SD). The levels
of itaconic acid were determined by GC/MS measurements. Each bar represents itaconic acid levels (± SD). *P < 0.05, **P < 0.01. (B) Itaconic acid quantiﬁcation
(mM) in mouse microglial cells (BV-2 cell line) and mouse macrophages (RAW264.7 cell line) after 6 h of LPS stimulation at 10 ng/mL (gray bars). Untreated cells
were used as a control (black bars). Bars represent the mean of itaconic acid concentration (± SEM). **P < 0.01. Levels of mRNA (C) or itaconic acid (D) in
human A549 lung cancer cells transfected with the mouse Irg1 overexpressing plasmid (pmIrg1). Metabolites and RNA extractions were performed 24 h after
transfection. Real-time RT-PCR results are normalized using L27 as a housekeeping gene and are shown as average expression fold change (± SEM). *P < 0.05,
**P < 0.01. (E) RAW264.7 cells were treated with LPS (10 ng/mL) at different time points and analyzed for Irg1 expression and itaconic acid concentration (mM).
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isotopologues (Fig. 2A). If the decarboxylation is performed by
a CAD homolog, the ﬁrst carbon atom of the molecule is expected
to be removed during the decarboxylation, resulting in M1 iso-
topologues of itaconic acid. In our experimental setting, we de-
termined 45% of the citric acid molecules as M2 isotopologues,
whereas 38% of the itaconic acid molecules were M1 isotopologues
(Fig. 2B). We also found a signiﬁcant fraction of M2, M3, and M4
itaconic acid isotopologues. The M4 fraction of itaconic acid re-
ﬂects pyruvate carboxylase or reverse malic enzyme activity. Be-
cause of the symmetry of succinic acid, subsequent turns of the
tricarboxylic acid (TCA) cycle can result in M2 or M3 isotopologues
of itaconic acid.
The observations described so far strongly suggest that Irg1
encodes a mammalian enzyme that catalyzes the decarboxylation
of cis-aconitate to itaconic acid.
IRG1 Protein Puriﬁcation and CAD Activity Assay. To directly dem-
onstrate that the IRG1 protein catalyzes the decarboxylation of cis-
aconitate, we puriﬁed FLAG-tagged IRG1 protein from human
embryonic kidney 293T (HEK293T) cells transfected with a
pCMV6-Entry-Irg1 expression plasmid. As depicted in Fig. 3A,
protein extracts prepared from those cells catalyzed the conversion
of cis-aconitate to itaconic acid. No itaconic acid formation was
detected when extracts were prepared from cells transfected with an
empty vector. Furthermore, afﬁnity puriﬁcation of the extract pre-
pared from FLAG-Irg1 overexpressing cells clearly showed coelu-
tion of the cis-aconitate decarboxylase activity with a protein band
identiﬁed as IRG1 by SDS/PAGE (expected molecular weight
∼55 kDa for Flag-Irg1; Fig. 3B) and Western blot analysis using
anti-IRG1 antibody (Fig. 3C). SDS/PAGE analysis showed that
this puriﬁcation procedure yielded a homogenous preparation of
the IRG1 protein (Fig. 3B), demonstrating that the cis-aconitate
decarboxylase activity measured in the puriﬁed fractions was not
due to another contaminating protein.
Itaconic Acid Is Produced by Human Primary Macrophages but at
Lower Levels Compared with Mouse Cells. Because an Irg1 homol-
ogous gene is annotated in the human genome on chromosome
13, we were interested to further analyze IRG1 expression and
itaconic acid amounts in human immune cells. To investigate
this, we isolated CD14+ primary human monocytes from the
blood of different donors, cultured them for differentiation into
macrophages for 11 d, and stimulated an inﬂammatory response
with LPS (10 μg/mL) for 6 h. In line with our previous observa-
tions in mouse macrophages, we observed that IRG1 expression
in human peripheral blood mononuclear cell (PBMC)-derived
macrophages was highly up-regulated after LPS activation
compared with resting conditions in which IRG1 mRNA levels
were almost undetectable (Fig. 4A). Our results are in accor-
dance with those of Roach and colleagues (23), who analyzed
LPS-activated PBMCs’ transcriptional proﬁles and observed
IRG1 up-regulation compared with control conditions. At the
metabolite level, itaconic acid amounts were highly increased
under LPS-induced inﬂammatory conditions compared with
resting cells in which the metabolite was measured in low amounts
or below the detection limits (Fig. 4B). In line with the induction of
itaconic acid production, we observed elevated IRG1 expression
(Fig. 4C andD). A similar trend was also mirrored by the expression
of TNF-α mRNA, indicating that macrophages were activated (Fig.
S4). Compared with the intracellular itaconic acid concentration in
mouse immune cells, the concentration in human macrophages was
two orders of magnitudes lower (8 mM vs. ∼60 μM).
A major difference between mouse and human is the elevated
production of NO in mouse macrophages under inﬂammatory
conditions (24). It is well known that NO inhibits aconitase, the
A B
Fig. 2. (A) Synthesis pathway of itaconic acid in the TCA cycle. Itaconic acid can only contain one labeled carbon if produced in the ﬁrst round of the TCA
cycle (yellow-marked atoms). (B) Labeling of citric acid (black bars) and itaconic acid (gray bars) using glucose as a tracer in RAW264.7 macrophages. The major
fraction of labeled itaconic acid contains one isotope, whereas citric acid contains mainly two labeled atoms.
Fig. 3. Puriﬁcation of cis-aconitate decarboxylase from HEK293T cells
transfected with the pCMV6-Entry-Irg1 expression plasmid. (A) Extracts from
cells transfected with empty plasmid or Flag-Irg1 plasmid were loaded onto
an afﬁnity resin (Cell MM2, FlagM puriﬁcation kit, Sigma Aldrich) and pro-
teins were eluted with Flag peptide. Cis-aconitate decarboxylase activity was
measured in cell extracts and puriﬁcation fractions as described in Materials
and Methods. (B) A total of 12 μL of each protein fraction was loaded onto an
SDS/PAGE gel that was stained with Coomassie Blue. (C) Western blot analysis
of the same protein fractions was performed using an IRG1-speciﬁc antibody.
F1-F3, elution fractions; FT, ﬂow through; P, pellet; SN, supernatant; W, wash.
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enzyme producing the itaconic acid precursor cis-aconitate (25–
27). To test whether the NO-mediated inhibition of aconitase
has an effect on itaconic acid production, we silenced the in-
ducible nitric oxide synthetase (iNOS) gene to decrease NO
levels in mouse macrophage (Fig. S5 A and B). On the other
hand, we treated human PBMC-derived macrophages with the
intracellular NO donor, diethylamine NONOate (28), to elevate
the NO level in these cells (Fig. S6 A–C). We could not detect
any effect on intracellular itaconic acid levels in either case.
Based on these results, we assume that aconitase is not a rate-
limiting step for itaconic acid synthesis.
Finally, we transfected A549 human lung cancer cells with
a pCMV6 plasmid expressing human IRG1 cDNA (phIrg1) to
show CAD activity of human IRG1. We observed high amounts
of both IRG1 gene transcript and itaconic acid (0.044 ± 0.0018
mM) 24 h posttransfection (Fig. 4 E and F).
In Vivo Irg1 Expression and Itaconic Acid Production. To conﬁrm Irg1
expression and itaconic acid production in vivo, we intraperi-
toneally injected C57BL/6 mice with LPS (1 mg/kg) and har-
vested the peritoneal macrophages after 24 h. We were able to
measure high Irg1 mRNA expression levels correlating with high
amounts of intracellular itaconic acid compared with the saline-
injected mice (Fig. 5 A and B).
Itaconic Acid Inhibits Bacterial Growth and Contributes to Antimi-
crobial Activity of Mouse Macrophages. It has previously been
shown that itaconic acid has an antimicrobial activity by inhib-
iting isocitrate lyase (ICL) (29, 30), an enzyme of the glyoxylate
shunt (Fig. 6A). The glyoxylate shunt is not present in animals,
but is essential for the survival of bacteria growing on fatty acids
or acetate as the limiting carbon source (31). The strategy for
survival during chronic stages of infection entails a metabolic
shift in the bacteria’s carbon source to C2 substrates generated by
β-oxidation of fatty acids (31). Under these conditions, glycolysis
is decreased and the glyoxylate shunt is signiﬁcantly up-regulated
to allow anaplerotic maintenance of the TCA cycle and assimi-
lation of carbon via gluconeogenesis (32). Highly elevated levels
of ICL are observed in Mycobacterium tuberculosis grown on C2
sources (33) and shortly after uptake into human macrophages
(34). Furthermore, it has been shown that persistence of M. tu-
berculosis in macrophages and mice requires the glyoxylate shunt
enzyme ICL (35). In fact, M. tuberculosis cannot persist in macro-
phages when both isoforms of icl are genetically knocked out
(36). Because the glyoxylate shunt is exclusively found in pro-
karyotes, lower eukaryotes, and plants, it represents a unique
target for drug development (37).
To conﬁrm the antimicrobial effect of itaconic acid on bac-
terial replication (30), we cultured the pathogens M. tuberculosis
and S. enterica (both known to synthesize ICL for biosynthesis
through the glyoxylate shunt) in liquid minimal medium sup-
plemented with acetate as the unique carbon source to force the
bacterial metabolism to use the glyoxylate shunt.
We determined bacterial growth in this medium in the pres-
ence of increasing itaconic acid concentration and observed that
the effective concentration of itaconic acid varies depending on
the analyzed bacteria. The growth of M. tuberculosis in vitro was
completely inhibited at 25–50 mM itaconic acid concentrations
(Fig. 6B), whereas signiﬁcant effects were already observed at
10 mM for S. enterica (Fig. 6C). To exclude secondary toxic effects
of itaconic acid, we measured the growth of the bacteria on
glycerol or glucose as a carbon source. In this case, bacterial
metabolism does not rely on the glyoxylate shunt. Under these
conditions, itaconic acid does not affect the bacterial growth
(Figs. S7A and S8A). To further demonstrate the speciﬁcity of the
antimicrobial activity of itaconic acid, we performed the same
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Fig. 4. Human IRG1 expression and itaconic acid
production. Levels of mRNA and itaconic acid in
resting (Ctr) and LPS-activated (10 μg/mL) PBMC-
derived macrophages. RNA and metabolites extrac-
tions were performed after 6 h of stimulation. (A)
The levels of IRG1 mRNA were determined by real-
time RT-PCR and normalized using L27 as a house-
keeping gene. Each bar represents the average ex-
pression fold change of ﬁve different donors
(± SEM). (B) The corresponding levels of itaconic
acid were determined by GC/MS measurements.
Each bar represents itaconic acid levels (± SEM). *P <
0.05, **P < 0.01. (C and D) Differential IRG1 gene
expression analysis and itaconic acid production
between ﬁve different donors. (E and F) Levels of
mRNA (E) or itaconic acid (F) in human A549 lung
cancer cells transfected with the human IRG1 over-
expressing plasmid (phIrg1). Metabolites and RNA
extractions were performed 24 h after transfection.
Real-time RT-PCR results are normalized using L27 as
a housekeeping gene and are shown as average ex-
pression fold change (± SEM). *P < 0.05, **P < 0.01.
Fig. 5. Mouse peritoneal macrophages from eight saline- and seven LPS-
injected mice (1 mg/kg) were isolated and pooled 24 h after i.p. injection. (A)
Irg1 expression levels and (B) itaconic acid production were analyzed com-
pared with intraperitoneally saline-injected mice. Bars represent the mean
of three technical replicates (± SEM).
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bacterial growth experiments, but by supplementing the medium
with the itaconic acid precursor cis-aconitate. We observed that
bacteria grown in the presence of cis-aconitate elicited an even
more pronounced growth at different concentrations of this me-
tabolite in both bacteria (Figs. S7 B and C and S8B), thus in-
dicating that these bacteria started to use cis-aconitate as carbon
source, in strong opposition with the effect we observed with
itaconic acid.
It has been described that ICL exhibits additional methyl-
isocitrate lyase (MCL) activity inM. tuberculosis. MCL is required
for the detoxiﬁcation of propionyl-CoA through the methylcitrate
cycle (38, 39) (Fig. 6A). Propionyl-CoA accumulates during
β-oxidation of odd-chain fatty acids and is produced from cho-
lesterol of the host macrophages (40). As a result, inhibition of
ICL in M. tuberculosis could have an additional toxic effect in the
presence of propionate. To investigate the potential accentuated
inhibition of the bacterial growth under these conditions, we in-
cubated M. tuberculosis in glycerol with 0.1 μM propionate and
increasing concentrations of itaconic acid. Indeed, the combina-
tion of these two effects inhibited M. tuberculosis growth at 5–10
mM of itaconic acid (Fig. S7D), thus conﬁrming that MCL activity
of ICL is affected by the metabolite.
To further investigate the involvement of itaconic acid in the
antimicrobial activity of macrophages, we infected RAW264.7
cells with S. enterica and consequently observed an increased Irg1
expression associated with high intracellular amounts of itaconic
acid (Fig. S9 A and B). We saw that silencing of Irg1 gene ex-
pression resulted in a decrease of intracellular itaconic acid
concentration (Fig. S9B). We detected a signiﬁcantly larger
number of intracellularly viable bacteria in macrophages treated
with siRNA targeting Irg1 compared with those treated with an
unspeciﬁc control siRNA or with siRNA targeting murine aco-
nitase 2 (Aco2) 4 h after infection (Fig. 6D and Fig. S10).
Taken together, our results clearly demonstrate the importance
of Irg1 expression in macrophages during bacterial infection, thus
contributing to their antimicrobial armature.
Conclusion
In this study, we report that the Irg1 gene encodes an enzyme
synthesizing itaconic acid from the TCA cycle intermediate cis-
aconitate. We showed a strong up-regulation of both Irg1
transcript and itaconic acid synthesis in macrophages in response
to LPS activation. Furthermore, our data also show that IRG1-
mediated itaconic acid production contributes to the antimicro-
bial activity of macrophages.
The discovery of an inducible enzyme linked to the TCA cycle
and catalyzing the production of an antimicrobial metabolite is
reminiscent of the mechanism found in the urea cycle responsible
for the production of NO. iNOS is the enzyme that catalyzes the
production of the antimicrobial compound NO from L-arginine
(41) and, like IRG1, is induced in mouse macrophages and
microglial cells under inﬂammatory conditions. In addition to
other factors, NO and itaconic acid production by immune cells
seem to represent an intrinsic property of these cells to self-react
toward an inﬂammatory insult, and those metabolites seem to
confer a form of innate metabolic immunity to macrophages and
microglial cells.
Materials and Methods
Cell Culture. Primary human monocytic CD14+ cells were isolated in two
steps from blood samples provided by Red Cross Luxembourg. First, (PBMCs
were separated in 50-mL Leucoseptubes (Greiner) through Ficoll-Paque
Premium (GE Healthcare) density-gradient centrifugation at 1,000 × g for
10 min at room temperature with no brake. Second, CD14+ cells were pu-
riﬁed with magnetic labeling. Therefore, 2 μL of CD14 Microbeads (Miltenyi
Biotech) per 107 PBMCs were incubated for 30 min at 4 °C followed by
a positive LS column (Miltenyi Biotech) magnetic selection. The puriﬁed
CD14+ cells were differentiated in six-well plates for 11 d in RPMI1640
medium without L-glutamine and phenol red (Lonza) supplemented with
10% (vol/vol) human serum (A&E Scientiﬁc), 1% (vol/vol) penicillin/strepto-
mycin (Invitrogen), and 0.05% (vol/vol) L-glutamine (Invitrogen). The medium
was changed on days 4 and 7.
Four cell lines, speciﬁcally murine microglial BV-2 cells (42), murine mac-
rophages RAW264.7 (43) (ATCC TIB-71), human epithelial A549 lung cancer
cells (44) (ATCC CCL-185), and human HEK293T cells (45) were used for
the experiments.
Mouse i.p. Injection of LPS and Peritoneal Macrophages Isolation. All animal
procedures, such as handling and euthanasia, have been performed
according to the Federation of European Laboratory Animal Science Asso-
ciations (FELASA) guidelines for the use of animals in research, and were
institutionally approved by the Luxembourg Centre for System Biomedicine
animal user committee and authorized by the local governmental agencies
(Ministry of Health, Ministry of Agriculture, chief veterinarian of the Lux-
embourg government). Three-to-four-month-old SJL mice were injected i.p.
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Fig. 6. Effect of itaconic acid on the bac-
terial growth. (A) Schematic of the glyox-
ylate shunt and the 2-methylcitrate cycle.
(B) GFP-expressing M. tuberculosis bacteria
were cultured in 7H9 medium supplemented
with acetate, without (w/o) or with various
concentrations of itaconic acid (5, 10, 25, 50
mM). Growth was measured as relative
light units (RLU) at indicated time points.
Curves represent the mean of three tech-
nical replicates. (C) S. enterica was grown in
liquid medium with acetate, without (w/o)
or in the presence of different concen-
trations of itaconic acid (5, 10, 50, 100 mM).
The OD was measured every hour. Curves
are calculated in percent relative to time
0 and represent the mean of three in-
dependent experiments. (D) RAW264.7 cells
were transfected with either siRNA speciﬁc
for Irg1 (siIrg1) or with siRNA control (siNeg).
After 24 h, the cells were infected with
S. enterica at a multiplicity of infection of
1:10 and incubated for 1 h at 37 °C (Materials
and Methods). Bars represent the mean of
the numbers of bacteria per ml (± SEM)
obtained from three independent experi-
ments. *P < 0.05.
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with LPS (1 mg/kg) or with saline vehicle and were deeply anesthetized after
24 h by i.p. injection of 50 mg/kg of ketamine·HCl and 5 mg/kg xylazine·HCl.
Mice were then euthanized by cervical dislocation. Eight saline- and seven LPS-
injected mice were used for peritoneal macrophages isolation. A small incision
was made in the upper abdomen, and peritoneal macrophages were washed
out with 4–5 mL ice-cold sterile PBS/mouse and pooled into falcon tubes. The
cell suspension was pelleted in a cooled centrifuge for 5 min at 250 × g and the
resulting pellet was worked up for metabolites and RNA extractions.
M. tuberculosis Growth Analysis. GFP-expressing M. tuberculosis H37Rv bac-
teria (47) were generated using the plasmid 32362:pMN437 (Addgene),
kindly provided by M. Niederweis (University of Alabama, Birmingham, AL)
(48). 1 × 106 bacteria were cultured in 7H9 medium supplemented with
different carbon sources as indicated in a total volume of 100 μL in a black
96-well plate with a clear bottom (Corning Inc) sealed with an air-permeable
membrane (Porvair Sciences). Growth was measured as relative light units
at 528 nm after excitation at 485 nm in a ﬂuorescence microplate reader
(Synergy 2, Biotek) at indicated time points.
Statistical Analysis. For comparison of means between two different treat-
ments, the statistical analysis was done by the Student t test unless otherwise
indicated. Error bars indicate SD or SEM as speciﬁed in the text.
For more information on protein puriﬁcation and CAD activity assay, RNA
isolation and RT-PCR, SDS/PAGE and Western blotting, GC/MS sample
preparation and procedure as well as glucose labeling assay, please see SI
Materials and Methods.
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SI Materials and Methods
Cell Transfections. The ON-TARGETplus SMARTpool contain-
ing four different siRNA sequences, all speciﬁc to murine Irg1
(siRNA Irg1), murine iNOS (siRNA iNOS), murine aconitase
2 (siRNA Aco2), and the corresponding nontargeting control
(siRNA Ctr), were designed and synthesized by Thermo Scien-
tiﬁc Dharmacon.
RAW264.7 macrophages were transfected with Amaxa 4D-
Nucleofector Device (Lonza) using the Amaxa SG cell line
4D Nucleofector Kit for THP-1 cells according to the manu-
facturer’s instructions.
Brieﬂy, transfection with siRNA complexes was carried out
from pelleted and resuspended cells (1 × 106 cells per condition).
Transfection reagent and siRNA were prepared according to
manufacturer’s instructions (Amaxa). siRNAs were added at
a ﬁnal concentration of 100 nM. After the nucleofection pro-
cessing using “RAW264.7 (ATCC) program” on the Nucleo-
fection device, the cells were seeded at a density of 1 × 106 cells
per well in 12-well plates in DMEM supplemented with 10%
FBS and incubated for 24 h.
pCMV6-Irg1 overexpressing plasmid (4 μg, Mus musculus
immune responsive gene 1 transfection-ready DNA, OriGene),
in parallel with the empty plasmid (4 μg), was transfected into
1.5 × 106 A549 cells using Lipofectamine 2000 (Invitrogen) and
further incubated for 24 h. pCMV6-Entry-Irg1 plasmid was
transfected into HEK293T cells by the jetPEI procedure as
described previously (46) and further incubated for 48 h
before extraction.
Macrophages Bacterial Phagocytosis and Killing Assay. Untrans-
fected or transfected RAW264.7 macrophages (with unspeciﬁc
siRNA, Irg1-speciﬁc siRNA or mitochondrial aconitase-speciﬁc
siRNA) were seeded at a density of 25 × 104 per well in 48-well
plates in 250 μL DMEM complemented with 10% FBS at 37 °C
with 5% CO2. After 24 h, the cells were infected with S. enterica
serovar typhimurium at a multiplicity of infection of 1:10 (one
bacteria per 10 macrophages) or 1:1 (one bacteria per one mac-
rophage) and incubated for 1 h at 37 °C with 5% CO2. Macro-
phages were then washed with sterile PBS and resuspend in
DMEM complemented with 10% FBS and 100 μg/mL gentamicin
to kill noningested bacteria and further incubated for 1 h (this was
considered as time point 0 h) or 4 h (time point 4 h) at 37 °C with
5% CO2. After washing with sterile PBS, macrophages were dis-
rupted for 15 min with 250 μL dH2O to release intracellular
bacteria. The amount of viable intracellular bacteria was de-
termined by plating on Luria-Bertani agar plates using four dilu-
tions from 1:10 up to 1:10,000 and incubation overnight at 37 °C.
For metabolite extraction, macrophages were seeded at a density
of 75 × 104 per well in 12-well plates. Intracellular metabolites
were extracted and mRNA isolated at time point 0 h and time
point 4 h for GC/MS measurements and RT-PCR, respectively.
All conditions were performed in technical triplicates.
Protein Puriﬁcation and CAD Activity Assay. HEK293T cells were
extracted 48 h after transfection by scraping them into a lysis buffer
containing 25mMHepes, pH7.1, and1×protease inhibitormixture
(Roche). After two freeze/thaw cycles, cell extracts were incubated
for 30 min on ice in the presence of DNase I (200 U/mL extract;
Roche Applied Science) and 10 mM MgSO4. The crude cell ex-
tracts were centrifuged for 5 min at 16,000 × g (4 °C) and pellets
were resuspended in lysis buffer for SDS/PAGE analysis. Flag-Irg1
was puriﬁed from the supernatant using the FlagM puriﬁcation kit,
according to the manufacturer’s instructions (Sigma Aldrich).
About 3mgprotein were loaded onto 250 μL anti-Flag afﬁnity resin
and retained proteinswere eluted with a solution containing 200 μg/
mL Flag peptide (3 × 400 μL fractions). Protein purity was checked
by SDS/PAGEanalysis. Protein concentrationwasmeasured by the
Bradford assay using Bradford reagent (Bio-Rad).
Cis-aconitate decarboxylase activity wasmeasured by incubating
cell extracts or puriﬁed protein fractions (10 μL) at 30 °C and for 40
min in a reaction mixture containing 25 mMHepes, pH 7.1, and 1
mM cis-aconitate in a total volume of 100 μL. Reactions were
stopped by addition of 900 μL methanol/water (8:1) mix. After 10
min centrifugation at 16,100 × g and 4 °C, 100 μL of the super-
natant were collected and evaporated under vacuum at−4 °C using
a refrigerated CentriVapConcentrator (Labconco).
RNA Isolation and RT-PCR. Total RNA was puriﬁed from cultured
cells using the Qiagen RNeasy Mini Kit (Qiagen) per manu-
facturer’s instructions. First-strand cDNA was synthesized from
0.5 to 2 μg of total RNA using SuperScript III (Invitrogen) with 1
μL (50μM)/reaction oligo(dT)20 as primer. Individual 20 μL SYBR
Green real-time PCR reactions consisted of 2 μL of diluted cDNA,
10 μL of 2× iQ SYBR Green Supermix (Bio-Rad), and 0.5 μL of
each 10 μMoptimized forward and reverse primers in 7 μLRNase-
free water. Primer sequences designed using Beacon Designer
software (Bio-Rad), provided by Eurogentec, or directly designed
by Thermo Scientiﬁc, are available on request. For the human Irg1
primers, the NCBI/Primer-BLAST tool available at http://www.
ncbi.nlm.nih.gov/tools/primer-blast/ was used. The PCR was car-
ried out on a Light Cycler 480 (Roche Diagnostics), using a three-
stage program provided by the manufacturer: 10 min at 95 °C and
40 cycles of 30 s at 95 °C, 30 s at 60 °C, and 30 s at 72 °C followed by
10-s 70–95° melting curves. All experiments included three no-
template controls and were performed on three biological repli-
cates with three technical replicates for each sample. For stan-
dardization of quantiﬁcation, L27 was ampliﬁed simultaneously.
SDS/PAGE and Western Blotting Analysis. Heat-denatured protein
samples were separated on 10% SDS-polyacrylamide gels elec-
trophoresis followedby transfer tonitrocellulosemembranes 0.2μm
(Sigma). After blocking with 5% (wt/vol) dry milk in PBS, the
membrane was incubated overnight at 4 °C in primary anti-Irg1
antibody from rabbit (Sigma) diluted 1:500 in 1% BSA/PBS with
constant shaking. After three washing steps with PBS containing
0.1% Tween-20, the membrane was incubated with anti-rabbit
antibody coupled to horseradish peroxidase and revealed by
chemiluminescence using the Amersham ECL detection reagents
(GE Healthcare).
GC/MS Sample Preparation and Procedure. Cells grown in six-well
plateswerewashedwith1mLsaline solutionandquenchedwith 0.4
mL −20 °C methanol. After adding an equal volume of 4 °C cold
water, cells were collected with a cell scraper and transferred in
tubes containing 0.4 mL −20 °C chloroform. The extracts were vor-
texed at 1,400 rpm for 20 min at 4 °C and centrifuged at 16,000 × g
for 5 min at 4 °C. 0.3 mL of the upper aqueous phase was collected
in speciﬁc GC glass vials and evaporated under vacuum at −4 °C
using a refrigerated CentriVap Concentrator (Labconco). The
metabolite extractions of cells grown on 12-well plates were per-
formed using half of the volumes.
The interphase was centrifuged with 1 mL −20 °C methanol
at 16,000 × g for 5 min at 4 °C. The pellet was used for RNA
isolation.
Michelucci et al. www.pnas.org/cgi/content/short/1218599110 1 of 8
Metabolite derivatization was performed using an Agilent
Autosampler. Dried polar metabolites were dissolved in 15 μL of
2% methoxyamine hydrochloride in pyridine at 45 °C. After 30
min, an equal volume of 2,2,2-triﬂuoro-N-methyl-N-trimethylsilyl-
acetamide + 1% chloro-trimethyl-silane were added and held for
30 min at 45 °C. Metabolites extracted out of 12-well plates were
derivatized using half of the reagent volumes. GC/MS analysis is
described in SI Materials and Methods, GC/MS Analysis.
Glucose Labeling Assay. RAW264.7 macrophages were seeded at
a density of 1 × 106 per well in 12-well plates in DMEM sup-
plemented with 10% FBS and 1% penicillin/streptomycin at 37 °C
with 5% CO2. After 24 h, the medium was changed to DMEM
containing uniformly labeled 25 mM [U-13C] glucose (Cambridge
Isotope). Simultaneously, the cells were activated with 10 ng/mL
LPS. After 6 h of incubation, the metabolites were extracted.
S. enterica Growth Analysis. S. enterica serovar typhimurium bac-
teria were grown in liquid medium as detailed in the text in the
presence different concentrations of itaconic acid or cis-aconitate
(5, 10, 50, 100 mM). Growth was measured as OD at indicated
time points.
Mice. All animal procedures have been performed according to
the European Guidelines for the use of animals in research (86/
609/CEE). All efforts were made to minimize suffering. All an-
imals have been raised and crossed in an indoor animal house in
a 12-h light/dark cycle and have been provided with water and
food ad libitum.
Cell Culture.Mixed glial cell cultures were prepared from the brains
of newborn C57BL/6mice. After carefully removingmeninges and
large blood vessels, the brains were pooled and thenminced in cold
PBS solution. The tissuewasmechanically dissociatedwith Pasteur
pipettes and the resultant cell suspensionwaspassed through a21G
hypodermic needle. After washes and centrifugations, the mixed
glial cells were plated into poly-D-lysine (PDL, Sigma) coated six-
well plates (two brains per six-well plate) in DMEM (Invitrogen)
supplemented with 100 U/mL penicillin, 100 mg/mL streptomycin
(Sigma), and 10% heat-inactivated FBS (Invitrogen) in a water-
saturated atmosphere containing 5% CO2 at 37 °C. The medium
was replaced every 3–4 d. After 7–10 d, when the cultures reached
conﬂuence, microglia were detached by a 30-min shaking on a ro-
tary shaker (180 rpm). Detached cells, mainly microglia (>95%),
were then plated in multiwell plates in conditioned medium and
further incubated for 3 d.
BV2 retroviral-immortalized microglia (BV-2), human em-
bryonic kidney 293T (HEK293T), and RAW264.7 cell lines were
maintained in DMEM with or without sodium pyruvate, sup-
plemented with 10% heat-inactivated FBS (South American,
Invitrogen). No antibiotics were used for BV-2; 1% penicillin/
streptomycin were used for RAW264.7 and HEK293T cells.
A549 cells were cultivated in DMEM without sodium pyruvate
and supplemented with 10% heat-inactivated FBS and 1% peni-
cillin/streptomycin. Cells were grown and maintained according to
standard cell culture protocols and kept at 37 °C with 5% CO2.
For experiments, BV-2,RAW264.7, andA549 cells were seeded
into multiwell plates at a density of 0.5 × 105 (BV-2) and 1.0 × 105
(RAW264.7 and A549) cells/well (six-well plates). After 3 d of
culture, the cells were activated adding speciﬁc stimuli to the
culture medium.
LPS 055:B5 fromEscherichia coli (Sigma) was added at speciﬁed
time points and at different doses in mouse primary microglia (1
ng/mL), BV-2, and RAW264.7 (10 ng/mL) or peripheral blood
mononuclear cell (PBMC)-derived macrophages (10 μg/mL) to
obtain similar activation states because of the differences in sen-
sitivity between murine primary cultures and cell lines as well as
between mouse and human cells.
GC/MS Analysis. GC/MS analysis was performed using an Agilent
6890GCequippedwitha30mDB-35MScapillary column.TheGC
was connected to an Agilent 5975C MS operating under electron
impact ionization at 70 eV. The MS source was held at 230 °C and
the quadrupole at 150 °C. The detector was operated in scan mode
and 1 μLof derivatized samplewas injected in splitlessmode.Helium
was used as carrier gas at a ﬂow rate of 1 mL/min. The GC oven
temperature was held at 80 °C for 6 min and increased to 300 °C at
6 °C/min. After 10 min, the temperature was increased to 325 °C at
10 °C/min for 4 min. The run time of one sample was 59 min.
NO Donor Treatments. Human PBMCs were seeded and differ-
entiated into macrophages as described previously. Diethylamine
NONOate (DEA NONOate, Sigma), an intracellular NO donor,
was added at different concentrations (1, 10, 100 μM) alone or
together with LPS (100 μg/mL). After 12 h of incubation, the
metabolites were extracted.
Griess Nitrite Assay. After 12 h, 180 μL of medium was harvested
and combined with 20 μL of 1 mM NaOH on ice to stop the
dissociation reaction. Levels of nitrite formed from the reaction
with H2O were determined using the Griess assay. In brief, 50 μL
of medium sample or nitrite ion chromatographic (IC) standard
(Sigma) was pipetted in triplicate in a 96-well plate. To each
well, equal volumes of 1× Griess Reagent (Sigma) were added.
Absorbance was read at 540 nm and nitrite concentrations were
calculated.
Sequence Alignment. Multiple sequence alignment of Cis-aconitic
acid decarboxylase (Aspergillus terreus), immune-responsive gene
1 protein homolog (human), immune-responsive gene 1 protein
(mouse), and iminodisuccinate epimerase (Agrobacterium tume-
faciens) was performed using MAFFT version 6 (1, 2) and visu-
alized with ESPript (3). Sequences were obtained from UniProt
Knowledgebase (UniProtKB) with the following accession num-
bers: B3IUN8 (CAD1), A6NK06 (IRG1 human), P54987 (IRG1
mouse), and Q1L4E3 (iminodisuccinate epimerase).
1. Katoh K, Toh H (2008) Recent developments in the MAFFT multiple sequence alignment
program. Brief Bioinform 9(4):286–298.
2. Katoh K, Misawa K, Kuma K, Miyata T (2002) MAFFT: A novel method for rapid
multiple sequence alignment based on fast Fourier transform. Nucleic Acids Res 30(14):
3059–3066.
3. Gouet P, Courcelle E, Stuart DI, Métoz F (1999) ESPript: Analysis of multiple sequence
alignments in PostScript. Bioinformatics 15(4):305–308.
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Fig. S1. Itaconic acid in mouse primary microglial cells. Primary microglial cells were treated for 6 h with LPS (1 ng/mL) (gray bars) or left untreated (black
bars). Bars represent the mean of itaconic acid levels (± SD). *P < 0.05.
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Fig. S2. Multiple sequence alignment of cis-aconitic acid decarboxylase (CAD) (Aspergillus terreus), immune-responsive gene 1 protein homolog (IRG1) (Homo
sapiens), immune-responsive gene 1 protein (IRG1) (Mus musculus), and iminodisuccinate (IDS) epimerase (Agrobacterium tumefaciens). Between CAD1 and
IRG1, ﬁve of eight active site residues are conserved. Conserved residues are shown in red; residues assumed to build active site are indicated with green
triangles below the alignment. Figure was drawn with ESPript. Sequences were obtained from UniProt Knowledgebase (UniProtKB) with the following ac-
cession numbers: B3IUN8 (CAD1), A6NK06 (IRG1 human), P54987 (IRG1 mouse), and Q1L4E3 (IDS epimerase).
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Fig. S3. Gene tree of mouse Irg1. Gene Tree was generated using the Ensembl gene orthology/paralogy prediction method pipeline (1). (Left) The evolu-
tionary history of Irg1 across species. (Right) A multiple sequence alignment of the associated proteins. Green bars show areas of amino acid alignment; white
areas are gaps in the alignment.
0.000
0.005
0.010
0.015
D1 D2 D3 D4 D5
TN
F-
α
m
RN
A
 le
ve
l
Ctr
LPS
**
**
**
**
**
Fig. S4. TNF-α expression in LPS-activated human PBMC-derived macrophages. RNA extractions were performed after 6 h of LPS (10 μg/mL) stimulation of
PBMC-derived macrophages from ﬁve different donors (D). The levels of TNF-α mRNA were determined by real-time RT-PCR and normalized using L27 as
a housekeeping gene. Each bar represents the average expression fold change of three technical replicates (± SEM). **P < 0.01.
1. Vilella AJ, et al. (2009) EnsemblCompara GeneTrees: Complete, duplication-aware phylogenetic trees in vertebrates. Genome Res 19(2):327–335.
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Fig. S5. (A) Levels of mRNA or (B) itaconic acid in LPS-activated RAW264.7 macrophages transfected with either siRNA speciﬁc for iNOS or with siRNA
nontargeting control (Ctr). Metabolites and RNA extractions were performed after 6 h of stimulation. The levels of iNOS mRNA were determined by real-time
RT-PCR and normalized using L27 as a housekeeping gene. Each bar represents the average expression fold change (± SEM) from three independent ex-
periments. The levels of itaconic acid were determined by GC/MS measurements. Each bar represents itaconic acid levels (± SEM). **P < 0.01.
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Fig. S6. (A–C) Itaconic acid levels in Ctr and LPS-activated (10 μg/mL) PBMC-derived macrophages from three donors treated with DEA NONOate at different
concentrations (1, 10, 100 μM). Metabolites were harvested after 12 h of stimulation and the levels of itaconic acid were determined by GC/MS measurements.
Each bar represents the mean of itaconic acid levels from three technical replicates (± SEM). (D) After 12 h, 180 μL of medium was harvested and combined with
20 μL 1 mM NaOH on ice to stop the dissociation reaction. Levels of nitrite were determined using the Griess assay and the concentrations were determined
against a nitrite standard curve. Bars represent the mean of nitrite concentration (μg/mL) from the three donors (± SEM).
Michelucci et al. www.pnas.org/cgi/content/short/1218599110 6 of 8
0500
1000
1500
2000
2500
0 1 2 3 4 5 6 7
RL
U
 
Time (d)
w/o
5mM
10mM
25mM
50mM
Acetate, Cis-aconitate
0
500
1000
1500
2000
2500
3000
3500
4000
4500
0 1 2 3 4 5 6 7
RL
U
 
Time (d)
w/o
5mM
10mM
25mM
50mM
BA Glycerol, Itaconate
C DGlycerol, Cis-aconitate Glycerol, Itaconate+Propionate
0
500
1000
1500
2000
2500
3000
3500
4000
4500
0 1 2 3 4 5 6 7
RL
U
 
Time (d)
w/o
5mM
10mM
25mM
50mM
0
500
1000
1500
2000
2500
3000
3500
4000
4500
5000
0 1 2 3 4 5 6 7
RL
U
 
Time (d)
w/o
5mM
10mM
25mM
50mM
Fig. S7. GFP-expressing Mycobacterium tuberculosis bacteria were cultured in 7H9 medium supplemented with different carbon sources, without (w/o) and
with various concentrations of itaconate (5, 10, 25, 50 mM) or cis-aconitate as indicated: (A) glycerol and itaconate, (B) acetate and cis-aconitate, (C) glycerol
and cis-aconitate, and (D) glycerol, propionate, and itaconate. Growth was measured as relative light units (RLU) at indicated time points. Curves represent the
mean of three technical replicates.
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Fig. S8. (A) Salmonella enterica was grown in liquid medium with glucose in the presence of itaconic acid, and the OD was measured every hour (h). Curves
represent the mean of two independent experiments. (B) S. entericawas grown in liquid medium with acetate as a unique carbon source without (w/o) or with
increasing concentrations of cis-aconitate (5, 10, 50 mM). The OD was measured every hour to record the bacterial growth. Curves are calculated in the percent
relative to time 0 and represent the mean of two independent experiments.
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Fig. S9. (A) Levels of Irg1 mRNA or (B) itaconic acid in RAW264.7 cells transfected with either siRNA speciﬁc for Irg1 or with siRNA control under S. enterica
infection at a multiplicity of infection (MOI) of 1:1 or 1:10 bacteria per macrophages. Infections were performed after 24 h of transfection and incubated for 0 h
or 4 h after 1 h gentamycin exposure. Macrophages were then lysed to extract RNA and metabolites. Bars represent the results from one experiment.
Fig. S10. Effect of Irg1 silencing in macrophages on the bacterial growth. Mouse RAW264.7 cells were transfected with either siRNA speciﬁc for Irg1 or with
siRNA speciﬁc for murine aconitase 2 (Aco2) as control. Macrophages were infected with S. enterica at an MOI of 1:1 or 1:10 bacteria per macrophages. In-
fections were performed after 24 h of transfection and incubated for 0 h or 4 h after 1 h gentamycin exposure. Bars represent the mean of the numbers of
colonies (± SEM) obtained from one experiment.
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